Sigmanomics
Back to all insights

Breaking News: QHSLab, OTCQB, and South Dakota State University Join Forces to Pursue NSF Grant for Revolutionary AIR GUIDDE Technology!

Breaking News: QHSLab, OTCQB, and South Dakota State University Join Forces to Pursue NSF Grant for Revolutionary AIR GUIDDE Technology!

NSF Recognition: A Testament to Innovation Driving Strategic Growth and Shareholder Value

WEST PALM BEACH, FL, Dec. 13, 2024 (GLOBE NEWSWIRE) — QHSLab Inc. (“the Company”) (OTCQB: USAQ), a leading provider of digital healthcare solutions and diagnostic technologies, is thrilled to announce that it has been invited by the prestigious National Science Foundation (NSF) to submit a full Phase I application for the development of the Airway Instantaneous Regional Guided Interface for Drug Delivery Efficiency (AIR-GUIDDE). This exclusive invitation, under the NSF Small Business Technology Transfer (STTR) program, underscores the transformative potential of AIR-GUIDDE and highlights the significant merits of the project, even at this early stage.

QHSLab Inc., in collaboration with OTCQB and South Dakota State University, is at the forefront of revolutionizing drug delivery efficiency with their innovative AIR-GUIDDE technology. This joint effort to pursue an NSF grant showcases their dedication to advancing healthcare solutions and diagnostic technologies for the betterment of society.

How Will This Affect Me?

As a consumer of healthcare services and potential beneficiary of enhanced drug delivery technologies, the development of AIR-GUIDDE could lead to more effective and targeted treatment options. This innovative technology has the potential to improve the delivery of medications, making treatments more efficient and reducing side effects for patients like you.

How Will This Affect the World?

The collaboration between QHSLab, OTCQB, and South Dakota State University to pursue an NSF grant for AIR-GUIDDE technology has the potential to impact the world of healthcare on a global scale. By introducing a revolutionary drug delivery system that enhances efficiency and accuracy, this technology could revolutionize the way medications are administered worldwide, improving patient outcomes and advancing healthcare innovation.

Conclusion

The partnership between QHSLab, OTCQB, and South Dakota State University in pursuing an NSF grant for the development of AIR-GUIDDE technology signifies a major milestone in the advancement of healthcare solutions. This collaboration highlights the commitment to innovation and strategic growth, ultimately aiming to drive value for shareholders and improve healthcare outcomes for people around the world.

more insights

“Navigating the Storm: Ethereum’s Struggle with Leadership and Market Demand”

January 24, 2025

Ethereum’s Uncertain Path Forward Challenges Facing the Ethereum Foundation Ethereum’s path forward is becoming increasingly uncertain, with growing calls for leadership reform to address significant governance challenges. The Ethereum Foundation, the organization responsible for overseeing the development of the Ethereum platform, is facing internal pressure and external market shifts that

Read more >
Sigmanomics

Menu

About

News

Signals

Risk Disclaimer: Sigmanomics is a financial portal that provides news and analysis about the different financial markets. The articles that we serve on the portal depend solely on the opinion and analysis of our economists which in no way are intended to incite a visitor of the website or an investor to trade or sell/buy a certain instrument. It is the responsibility of the visitor / trader only to evaluate his trading strategies and whether he is capable of trading with taking into consideration that losing all the capital invested is a possibility. The visitor should seek an independent professional financial advisor to discuss his or her trading strategies. Moreover, the provided rates for the different instruments are indicative only and cannot be used for trading purposes. Therefore, no responsibility can be imposed on sigmanomics.com.com and the company operating the portal for any loss of money that may occur to the visitor by using the website.